Literature DB >> 15294077

Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA).

Jan Stenvang Jepsen1, Henrik M Pfundheller, Anne E Lykkesfeldt.   

Abstract

Locked nucleic acid (LNA) is a nucleic acid analog with very high affinity to complementary RNA and a promising compound in the field of antisense research. The intracellular localization and quantitative uptake of oligonucleotides containing LNA were found to be equivalent to those of phosphorothioate oligonucleotides (PS AONs). The antisense efficiency of LNA-containing oligonucleotides was systematically compared with standard PS AONs targeting expression of two endogenous proteins in the human breast cancer cell line MCF-7, namely, the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and the estrogen receptor alpha (ERalpha). For downregulation of both target proteins, the most efficient design was achieved with oligonucleotides containing LNA monomers in the extremities and a central gap of PS-linked DNA monomers, so called LNA gapmers. Such LNA gapmers caused more potent downregulation of the targeted proteins than PS AONs, whereas fully modified LNA AONs or LNA mixmers (LNA nucleotides interspersed) were inactive.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294077     DOI: 10.1089/1545457041526281

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  4 in total

Review 1.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

2.  Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.

Authors:  Ellen Marie Straarup; Niels Fisker; Maj Hedtjärn; Marie W Lindholm; Christoph Rosenbohm; Vibeke Aarup; Henrik Frydenlund Hansen; Henrik Ørum; Jens B Rode Hansen; Troels Koch
Journal:  Nucleic Acids Res       Date:  2010-07-08       Impact factor: 16.971

3.  Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

Authors:  Melissa L Tursiella; Emily R Bowman; Keith C Wanzeck; Robert E Throm; Jason Liao; Junjia Zhu; Clare E Sample
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

4.  In vitro inhibition of porcine reproductive and respiratory syndrome virus replication by short antisense oligonucleotides with locked nucleic acid modification.

Authors:  Lingyun Zhu; Junlong Bi; Longlong Zheng; Qian Zhao; Xianghua Shu; Gang Guo; Jia Liu; Guishu Yang; Jianping Liu; Gefen Yin
Journal:  BMC Vet Res       Date:  2018-03-26       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.